Sowell Financial Services LLC Novo Cure LTD Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$130.4 - $225.58 $42,901 - $74,215	-329 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$124.11 - $190.17 $17,623 - $27,004	-142 Reduced 30.15%	329 $64,000
Q4 2020 Jan 13, 2021	SELL	$112.16 - $174.14 $117,207 - $181,976	-1,045 Reduced 68.93%	471 $82,000
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $21,188 - $40,628	-365 Reduced 19.4%	1,516 $169,000
Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $64,578 - $84,008	1,129 Added 150.13%	1,881 $112,000
Q1 2020 May 12, 2020	SELL	$57.05 - $95.75 $5,476 - $9,192	-96 Reduced 11.32%	752 $51,000
Q4 2019 Feb 07, 2020	BUY	$68.3 - $93.8 $49,585 - $68,098	726 Added 595.08%	848 $71,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $7,546 - $11,931	122 New	122 $9,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.1B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.